The demonstration that vector silencing enhanced the Kb:OVA257-264 epitope-specific CD8 T cell response in the brain prompted us to determine if this approach increases efficacy of picornavirus vaccination against CNS tumors. The gene discussed is CD8A; the disease is central nervous system neoplasm.